Who are 10x Genomics's decision-makers?
10x Genomics's official leadership and governance pages are the safest source for named executives.
- Primary buyers
- finance, procurement, IT, security, operations, legal, and the business owner tied to the active initiative
- Company status
- Public company; Nasdaq: TXG
- HQ
- Pleasanton, CA
- Category
- Single-cell and spatial biology tools
- Decision style
- Public-company buying committee
- Best source
- Official leadership or IR page
- 10x Genomics executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- 10x Genomics finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, capital allocation, and budget discipline.
- 10x Genomics operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operating-improvement purchases.
Who leads 10x Genomics?
10x Genomics's named leaders should be verified directly on the company's official leadership, governance, or investor-relations page. The profile intentionally avoids invented executive emails and treats official contact routes as the safe default.
Who owns buying decisions at 10x Genomics?
The buying committee depends on the offer. Finance and procurement usually control commercial approval, while IT, security, product, operations, legal, field, clinical, industrial, or commercial leaders shape requirements and vendor evaluation.
How should sellers map the account?
Start with headquarters and public leadership, then map functional owners by product area. Use filings, job posts, partner announcements, security pages, engineering posts, and investor materials to identify the active initiative behind a buying cycle.
As of June 2026.Sources:10x Genomics official website10x Genomics investor relations or company newsBuiltWith public technology profile
10x Genomics — frequently asked questions
